Solving Disease Challenges
Jorge discusses the challenges of developing therapies for diseases with known biological problems versus those with unknown biological basis, highlighting the risks and failures in developing Alzheimer's therapies. He emphasizes the importance of focusing on opportunities with less science risk and more engineering and scale risk, offering support to entrepreneurs in those areas.In this clip
From this podcast

The a16z Podcast
a16z Podcast | Taking the Pulse on Bio
Related Questions